At Roche, it is not just about treating patients - it is about traveling this uphill road with them and their families. Improving access to effective, quality healthcare requires a combination of products, services, systems and resources. In an attempt to overcome this challenge, Roche Pharma India works dedicatedly to reduce such barriers, enable access and meet patients’ unmet needs. Know more about The Blue Tree Program with this film.
People living with cancer, hemophilia and rare diseases have a variety of support needs and we recognize them. Patient assistance matters as much as clinical efficacy and healthcare delivery. Impactful patient assistance is linked to improved patient outcomes and lower costs, and contributes significantly to creating healthcare access in the country. Towards this, The Blue Tree Program provides a bouquet of 11 services to help patients and their caregivers navigate the complex treatment journey.
Roche Pharma India’s The Blue Tree Program offers support to cancer, hemophilia and rare disease patients during their entire treatment journey — from diagnosis to completion of therapy. It is a comprehensive patient support initiative that is designed to take care of the multiple hurdles that a patient has to go through during the course of receiving treatment. Here’s a snapshot of the services offered under The Blue Tree Program:
Since its launch, The Blue Tree Program has:
Benefited 11000+ patients across India
Partnered with 750+ doctors
Partnered with 300+ cancer care centers pan India
Conducted 1800+ diagnostic tests
The Blue Tree Program was showcased as an effective and unique patient support programme at the United General Assembly (UNGA) Week – as part of the 72nd session of the UNGA in September 2017.
To avail support from The Blue Tree program, patients and caregivers can reach out to their healthcare providers or connect with The Blue Tree administrator on toll-free number
The Blue Tree app is available for download on both Google Play Store and App Store.